Acasti Pharma (CVE:ACST) Trading 1.8% Higher – Here’s What Happened

by · The Markets Daily

Acasti Pharma Inc. (CVE:ACST – Get Free Report) was up 1.8% during mid-day trading on Thursday . The stock traded as high as C$0.58 and last traded at C$0.58. Approximately 2,450 shares traded hands during trading, a decline of 63% from the average daily volume of 6,576 shares. The stock had previously closed at C$0.57.

Acasti Pharma Stock Performance

The stock’s 50-day moving average is C$0.58 and its 200 day moving average is C$0.58. The stock has a market cap of C$25.87 million, a price-to-earnings ratio of -1.07 and a beta of 1.22. The company has a debt-to-equity ratio of 0.52, a current ratio of 9.74 and a quick ratio of 9.41.

About Acasti Pharma

(Get Free Report)

Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Featured Stories